Expectations are sometimes very amusing things. You have them and then find yourself surprised when they prove wrong. It's like assuming every classic diner will serve apple pie only to find some that don't. So, browsing through the news, I was surprised to come across a news item about the latest words of wisdom to be published by the American College of Physicians. For those of you who don't follow medical affairs, the ACP was founded in 1915 and has 120,000 internists in its organization. This makes it the largest specialty organization in the medical field. You expect this kind of body to be on top of things. With advances in medical technology stunning us every week, you look to the ACP for leadership, promoting excellence and professionalism among its members by issuing guidelines and advice based on the latest evidence. So here is their latest offering. It's finally official. The best treatment for erectile dysfunction is a PDE5 inhibitor pill.
The ACP did talk wisely about dosages, indicating that slightly higher dosages yielded the best results. Their advice was also balanced. Yes, there were occasional side effects. Indeed, the committee members called for more research to determine which of the PDE5 inhibitors caused the most problems. But, as it stands, most men preferred a hard erection and were prepared to tolerate the odd runny or blocked-up nose. Why, you might ask, has the ACP decided to talk now. The answer is quite revealing. The US has an ageing population and more men are reaching an age when they may expect problems of ED. In 2025, the ACP estimates there will be more than 300 million men seeking help. This makes the ED market worth billions so they decided to endorse viagra now. Significantly, only one of the authors of this report disclosed funding from the ED manufacturers so that makes this report timely, balanced and reliable.







